{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:34Z","timestamp":1753891234560,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Primary bone diffuse large B-cell lymphoma (PB-DLBCL) has been rarely reported because of its low incidence. The optimal treatment plan for patients with relapsed\/refractory PB-DLBCL remains controversial. In this study, we present a case of a 57-year-old patient with refractory PB-DLBCL to better understand this disease. The patient developed lumbosacral\/low extremity pain. A lumbar magnetic resonance imaging (MRI) revealed skeletal lesions with osteolysis in L4-L5 and S1. With the failure of multi-line chemotherapy, the patient developed paralysis of both lower limbs. 18-Fluorinefluorodeoxyglucose positron emission tomography\/computed tomography (18F-FDG PET\/CT) and MRI showed new lesions in the femoral head, cervical and thoracic vertebrae. We tried to treat the patient with adjuvant radiotherapy and 10 courses of high-dose methotrexate (HD-MTX)-based monotherapy, after which the patient was able to walk and achieved complete remission (CR). To the best of our knowledge, this is the first attempt to use local radiotherapy combined with an HD-MTX regimen successfully for the treatment of refractory PB-DLBCL.<\/jats:p>","DOI":"10.3389\/fmed.2022.989590","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:14:15Z","timestamp":1671599655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhiya","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifeng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ctrv.2015.02.001","article-title":"Primary and secondary bone lymphomas.","volume":"41","author":"Messina","year":"2015","journal-title":"Cancer Treat Rev."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/srep28834","article-title":"Clinical characterization and outcome of primary bone lymphoma: a retrospective study of 61 Chinese patients.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1177\/2040620720958538","article-title":"Primary lymphoma of bone: a population-based study of 2558 patients.","volume":"11","author":"Liu","year":"2020","journal-title":"Ther Adv Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijrobp.2015.01.014","article-title":"Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.","volume":"92","author":"Tao","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"B5","doi-asserted-by":"publisher","first-page":"iv62","DOI":"10.1093\/annonc\/mdx223","article-title":"Newly diagnosed and relapsed mantle cell lymphoma: Esmo clinical practice guidelines for diagnosis, treatment and follow-up.","author":"Dreyling","year":"2017","journal-title":"Ann Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1148\/rg.236025056","article-title":"Primary bone lymphoma: radiographic-Mr imaging correlation.","volume":"23","author":"Krishnan","year":"2003","journal-title":"Radiographics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1007\/s11999-013-2991-x","article-title":"Malignant lymphoma of bone: a review of 119 patients.","volume":"471","author":"Demircay","year":"2013","journal-title":"Clin Orthop Relat Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"Chop chemotherapy plus rituximab compared with chop alone in elderly patients with diffuse large-B-cell lymphoma.","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/s1470-2045(06)70664-7","article-title":"Chop-like chemotherapy plus rituximab versus chop-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the mabthera international trial (Mint) group.","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2020.100326","article-title":"Primary bone lymphoma: clinical presentation and therapeutic considerations.","volume":"25","author":"M\u00fcller","year":"2020","journal-title":"J Bone Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/bjh.12714","article-title":"Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the Ielsg 14 Study).","volume":"164","author":"Messina","year":"2014","journal-title":"Br J Haematol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1080\/10428194.2018.1564823","article-title":"Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse.","volume":"60","author":"Goldschmidt","year":"2019","journal-title":"Leuk Lymphoma."},{"key":"B13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jpeds.2008.11.030","article-title":"Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.","volume":"154","author":"Pati\u00f1o-Garc\u00eda","year":"2009","journal-title":"J Pediatr."},{"key":"B14","first-page":"125","article-title":"Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin\u2019s lymphoma of unfavorable histology.","author":"Canellos","year":"1981","journal-title":"Cancer Treat Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/jco.1994.12.7.1443","article-title":"Methotrexate pharmacokinetics and prognosis in osteosarcoma.","volume":"12","author":"Graf","year":"1994","journal-title":"J Clin Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10147-007-0750-2","article-title":"Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil.","volume":"13","author":"Mizoshita","year":"2008","journal-title":"Int J Clin Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/(sici)1097-0142(19971015)80:8+3.3.co;2-m","article-title":"Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma.","author":"Harvey","year":"1997","journal-title":"Cancer."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/art.1780371210","article-title":"Methotrexate concentrations in synovial membrane and trabecular and cortical bone in rheumatoid arthritis patients.","volume":"37","author":"Bologna","year":"1994","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1002\/onco.13603","article-title":"Standardized supportive care documentation improves safety of high-dose methotrexate treatment.","volume":"26","author":"Alsdorf","year":"2021","journal-title":"Oncologist."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.989590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T05:14:18Z","timestamp":1671599658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.989590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":19,"alternative-id":["10.3389\/fmed.2022.989590"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.989590","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"article-number":"989590"}}